• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GONG Yinhua,ZHANG Ping,HONG Xiao,CHEN Rong,XU Wenjie,ZHU Jianguo.Application of subject-achieving quality control circle in improving pharmaceutical care for patients with chronic hepatitis B[J].Journal Of Pharmaceutical Research,2022,41(2):131-135,140[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2438times   Download 2510次 QR Code for this article
Scan with your phone!
课题达成型品管圈在提升慢性乙肝患者药学服务中的应用
龚银华,张萍,洪晓,陈蓉,徐文杰,朱建国
Font:Larger+|Default|Smaller-
(苏州大学附属第一医院药学部,江苏 苏州 215006)
摘要:
目的 探讨课题达成型品管圈(Quality Control Circle,QCC)在提升慢性乙肝患者药学服务体系中的应用效果,提高患者对于治疗的依从性和提高药师工作效率,为慢性乙肝患者的管理提供理论支持。方法 选定“提升慢性乙肝患者药学服务”为本期品管圈活动主题,按照课题达成型品管圈的十大步骤开展活动,评价活动前后有形成果和无形成果。通过QCC活动分析对慢性乙肝患者的药学服务不足的原因,拟定重组管理团队、多维度药学服务、临床应用依从性研究服务于慢性乙肝患者等对策改善药学服务质量。结果 开展 QCC活动后,对慢性乙肝患者进行药学服务,选取的使用集中采购恩替卡韦的人群中肝功能异常百分比由改善前的18.75%降低至7.14%(P<0.05),肝功能ALT复常率由改善前的81.25%提高至改善后的88.39%(P<0.05),HBV-DNA转阴率由改善前86.61%提高至98.21%(P<0.05)。圈员荣誉感、责任心、自信心、QCC手法、沟通协调和团队凝聚力等活动能力均有明显提高。结论 课题达成型品管圈活动适用于提升慢性乙肝患者药学服务等较复杂的课题,能够有效提高工作效率。QCC活动的开展提升了慢性乙肝患者的药学服务,体现了临床药师的专业服务水平,对于提升医院药学服务质量具有显著意义。
关键词:  品管圈  课题达成型  慢性乙肝管理  依从性
DOI:10.13506/j.cnki.jpr.2022.02.014
基金项目:
Publication Date:February 25, 2022
Application of subject-achieving quality control circle in improving pharmaceutical care for patients with chronic hepatitis B
GONG Yinhua,ZHANG Ping,HONG Xiao,CHEN Rong,XU Wenjie,ZHU Jianguo
(The First Affiliated Hospital of Soochow Universiyt,Suzhu 215006,China)
Abstract:
Objective To explore the application effect of QCC in improving the pharmaceutical care system for patients with chronic hepatitis B, and to provide theoretical support for the management of patients with chronic hepatitis B.Methods Select the theme of "Improving Pharmaceutical Services for Patients with Chronic Hepatitis B" as the theme of this quality control circle and carry out activities in accordance with the ten steps of the quality control circle of the subject-achieving quality control circle. Before and after the evaluation Tangible fruit and intangible fruit. Analyze the causes of insufficient pharmaceutical services for patients with chronic hepatitis B through QCC activities, and formulate strategies to improve the quality of pharmaceutical services such as reorganizing the management team, multi-dimensional pharmaceutical services, and clinical research to serve patients with chronic hepatitis B. Results After the QCC activities were carried out, in the management of chronic hepatitis B patients, the percentage of abnormal liver function among the selected people who used centralized purchase of entecavir decreased from 18.75% before improvement to 7.14%, and the rate of liver function ALT reversion increased from 81.25% before improvement To 88.39% after improvement, the HBV-DNA conversion rate increased from 86.61% before improvement to 98.21%. Circle members' sense of honor, sense of responsibility, self-confidence, QCC techniques, communication and coordination and team cohesion and other activities have been significantly improved. Conclusion The project-achieving quality control circle activities are suitable for more complex subjects such as improving the pharmaceutical care of chronic hepatitis B patients, and can effectively improve work efficiency. The development of QCC activities has improved the pharmacy services for patients with chronic hepatitis B, reflects the professional service level of clinical pharmacists, and is of significant significance for improving the quality of hospital pharmacy services.
Key words:  Quality control circle  Project achievement type  Chronic hepatitis B management  Compliance
Today's Visits:468    Total Visits:2383167
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.